invest1 publisher
FDA investigates possible link between GLP-1 drugs and rare eye condition amid New Jersey lawsuits
The FDA is investigating whether GLP-1 drugs cause sudden vision loss, and the New Jersey filings number in the dozens. The market those drugs sell into is projected at $92 billion this year.
Publishers:en.sedaily.com
Reality
- Evidence45
- Adoption74
- Hype gap+14
- Incentives62
- Confidence42